Diogo Manuel de Jesus Mendes


AuthID: R-00M-1MG

Confirmed Publications: 73



21
TITLE: RISK OF INFECTIONS AMONG JAK INHIBITORS USED IN RHEUMATOID ARTHRITIS: A NETWORK META-ANALYSIS OF CLINICAL TRIALS  Full Text
AUTHORS: Penedones, A; Alves, C; Mendes, D ; Batel Marques, F;
PUBLISHED: 2021, SOURCE: EACPT Virtual Meeting - Focus on Progress in Clinical Pharmacology in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, VOLUME: 77, ISSUE: SUPPL 1
INDEXED IN: WOS
IN MY: ORCID | CIÊNCIAVITAE
22
TITLE: A Systematic Review of Economic Studies Evaluating Ophthalmic Drugs: An Analysis of the Health-state Utilities  Full Text
AUTHORS: Ribeiro, I; Marques, FB; Mendes, D ; Alves, C;
PUBLISHED: 2020, SOURCE: OPHTHALMIC EPIDEMIOLOGY, VOLUME: 27, ISSUE: 5
INDEXED IN: Scopus WOS CrossRef: 1
IN MY: ORCID | CIÊNCIAVITAE
23
TITLE: Comparative risk of infections among JAK inhibitors used in rheumatoid arthritis: A network meta-analysis of clinical trials  Full Text
AUTHORS: Carlos Alves; Diogo Mendes ; Ana Penedones; Francisco Batel Marques;
PUBLISHED: 2020, SOURCE: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, VOLUME: 29
INDEXED IN: WOS
IN MY: ORCID | CIÊNCIAVITAE
24
TITLE: Comparative safety of JAK inhibitors in patients with rheumatoid arthritis: A network meta-analysis of clinical trials  Full Text
AUTHORS: Carlos Alves; Diogo Mendes ; Ana Penedones; Francisco Batel Marques;
PUBLISHED: 2020, SOURCE: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, VOLUME: 29
INDEXED IN: WOS
IN MY: ORCID | CIÊNCIAVITAE
25
TITLE: Intensive safety monitoring program of antineoplastic medicines: A pilot study in a Portuguese oncology hospital  Full Text
AUTHORS: Mendes, D ; Rigueiro, G; Silva, RS; Penedones, A; Alves, C; Sousa, G; Batel Marques, F;
PUBLISHED: 2020, SOURCE: JOURNAL OF ONCOLOGY PHARMACY PRACTICE, VOLUME: 26, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef: 2
IN MY: ORCID | CIÊNCIAVITAE
26
TITLE: Outcomes From the First 6 Years of Operation of the Central Portugal Pharmacovigilance Unit
AUTHORS: Batel Marques, F; Penedones, A; Mendes, D ; Alves, C;
PUBLISHED: 2020, SOURCE: JOURNAL OF PATIENT SAFETY, VOLUME: 16, ISSUE: 3
INDEXED IN: Scopus WOS CrossRef: 1
IN MY: ORCID | CIÊNCIAVITAE
27
TITLE: Polypharmacy as an independent risk factor for serious adverse drug reactions: A systematic review  Full Text
AUTHORS: Diogo Mendes ; Rita Gomes; Carlos Alves; Francisco Batel Marques;
PUBLISHED: 2020, SOURCE: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, VOLUME: 29
INDEXED IN: WOS
IN MY: ORCID | CIÊNCIAVITAE
28
TITLE: Real-world intensive safety monitoring of biosimilars rituximab and trastuzumab in a Portuguese oncology hospital  Full Text
AUTHORS: Mendes, D ; Abrantes, J; Rigueiro, G; Pais, AF; Penedones, A; Alves, C; Batel Marques, F;
PUBLISHED: 2020, SOURCE: JOURNAL OF ONCOLOGY PHARMACY PRACTICE, VOLUME: 27, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef: 8
IN MY: ORCID | CIÊNCIAVITAE
29
TITLE: REAL-WORLD OUTCOMES VERSUS CLINICAL TRIALS RESULTS WITH DIPEPTIDYL PEPTIDASE-4 INHIBITORS: A SYSTEMATIC REVIEW PROTOCOL
AUTHORS: Batel Marques, F; Pereira, D; Mendes, D ; Alves, C; Penedones, A;
PUBLISHED: 2020, SOURCE: DIABETES TECHNOLOGY & THERAPEUTICS, VOLUME: 22
INDEXED IN: WOS
IN MY: ORCID | CIÊNCIAVITAE
30
TITLE: Rectus sheath hematoma in patients receiving subcutaneous enoxaparin: A case series of five patients
AUTHORS: Mendes, D ; Penedones, A; Martins, M; Cavadas, S; Alves, C; Batel Marques, F;
PUBLISHED: 2020, SOURCE: Clinical Case Reports in CLINICAL CASE REPORTS, VOLUME: 8, ISSUE: 12
INDEXED IN: Scopus WOS CrossRef: 5 Handle
Page 3 of 8. Total results: 73.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service